(Harrison et al., 2020) Intriguingly, blockade of NLRP3 inflammasome activation in KCs and MoMFs contributed to the amelioration of NASH, by attenuating hepatic lipid accumulation. This evidence concerns the gene TBCE and metabolic dysfunction-associated steatohepatitis.